Literature DB >> 34104915

Cerebral sinovenous thrombosis in children: A single-center experience.

İpek Dokurel Çetin1, Cenk Eraslan2, Erdem Şimşek1, Seda Kanmaz1, Hepsen Mine Serin1, Deniz Yılmaz Karapınar3, Sanem Keskin Yılmaz1, Gül Aktan1, Hasan Tekgül1, Sarenur Gökben1.   

Abstract

OBJECTIVE: The study aimed to evaluate the patients with a diagnosis of cerebral sinovenous thrombosis in terms of clinical findings, etiology and underlying risk factors, imaging findings, treatment, and prognosis in the long term.
MATERIALS AND METHODS: Medical records of 19 patients whose ages ranged between 0 days and 17 years with clinical and radiological cerebral sinovenous thrombosis in Ege University Department of Child Neurology were retrospectively evaluated.
RESULTS: Nine of nineteen cases were female (47.3%). The median age was 84 months (0-201 months). The most common complaint at the presentation was headache (n=12) and the most common physical examination finding was papilledema (n=11). In etiology, otitis/mastoiditis in three cases, iron deficiency anemia in three cases, sinusitis in two cases, catheter use in four cases, Behçet's disease in three cases were determined. The most common observed genetic factors causing thrombosis was methylenetetrahydrofolate reductase mutation. The transverse sinus (68.4%) is the sinus where thrombosis is most frequently observed. As a result of an average follow-up of 12 months (2-72 months), hemiparesis (n=3/19, 15.7%) and epilepsy (n=5/19, 26.3%) were recorded as sequelae findings, and no mortality was observed.
CONCLUSION: In cases presenting with headache, evaluation of papilledema on funduscopic examination should not be skipped. Neurological imaging should be performed in the change of consciousness of poor feeding infants and children with infections in the head and neck area or underlying chronic diseases. When cerebral sinovenous thrombosis is detected, anticoagulant therapy should be started immediately.
Copyright © 2021 Turkish Pediatric Association.

Entities:  

Keywords:  Cerebral sinovenous thrombosis; neuroimaging; pediatric stroke; treatment

Year:  2021        PMID: 34104915      PMCID: PMC8152651          DOI: 10.5152/TurkArchPediatr.2021.20073

Source DB:  PubMed          Journal:  Turk Arch Pediatr        ISSN: 2757-6256


  43 in total

Review 1.  Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis.

Authors:  Linda L Humphrey; Rongwei Fu; Kevin Rogers; Michele Freeman; Mark Helfand
Journal:  Mayo Clin Proc       Date:  2008-11       Impact factor: 7.616

Review 2.  Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Gustavo Saposnik; Fernando Barinagarrementeria; Robert D Brown; Cheryl D Bushnell; Brett Cucchiara; Mary Cushman; Gabrielle deVeber; Jose M Ferro; Fong Y Tsai
Journal:  Stroke       Date:  2011-02-03       Impact factor: 7.914

3.  Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients.

Authors:  Vanesa Caruso; Licia Iacoviello; Augusto Di Castelnuovo; Sergio Storti; Guglielmo Mariani; Giovanni de Gaetano; Maria Benedetta Donati
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

4.  Epidemiology of childhood stroke in Estonia.

Authors:  Rael Laugesaar; Anneli Kolk; Ulle Uustalu; Pilvi Ilves; Tiiu Tomberg; Inga Talvik; Kristel Köbas; Valentin Sander; Tiina Talvik
Journal:  Pediatr Neurol       Date:  2010-02       Impact factor: 3.372

5.  Multiple risk factors in neonatal sinovenous thrombosis.

Authors:  Yvonne W Wu; S P Miller; K Chin; A E Collins; S C Lomeli; N A Chuang; A J Barkovich; D M Ferriero
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

6.  Physiological anticoagulants and activated protein C resistance in childhood stroke.

Authors:  R S Riikonen; E M Vahtera; R M Kekomäki
Journal:  Acta Paediatr       Date:  1996-02       Impact factor: 2.299

7.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

8.  Long-term prognosis of cerebral venous sinus thrombosis in childhood.

Authors:  Els L L M De Schryver; Ingrid Blom; Kees P J Braun; L Jaap Kappelle; Gabriël J E Rinkel; A C Boudewyn Peters; Aag Jennekens-Schinkel
Journal:  Dev Med Child Neurol       Date:  2004-08       Impact factor: 5.449

Review 9.  Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young.

Authors:  E Steve Roach; Meredith R Golomb; Robert Adams; Jose Biller; Stephen Daniels; Gabrielle Deveber; Donna Ferriero; Blaise V Jones; Fenella J Kirkham; R Michael Scott; Edward R Smith
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

10.  Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias.

Authors:  Robert Clarke; Derrick A Bennett; Sarah Parish; Petra Verhoef; Mariska Dötsch-Klerk; Mark Lathrop; Peng Xu; Børge G Nordestgaard; Hilma Holm; Jemma C Hopewell; Danish Saleheen; Toshihiro Tanaka; Sonia S Anand; John C Chambers; Marcus E Kleber; Willem H Ouwehand; Yoshiji Yamada; Clara Elbers; Bas Peters; Alexandre F R Stewart; Muredach M Reilly; Barbara Thorand; Salim Yusuf; James C Engert; Themistocles L Assimes; Jaspal Kooner; John Danesh; Hugh Watkins; Nilesh J Samani; Rory Collins; Richard Peto
Journal:  PLoS Med       Date:  2012-02-21       Impact factor: 11.069

View more
  1 in total

Review 1.  Iron deficiency anemia and thrombosis risk in children-revisiting an old hypothesis.

Authors:  Hannah Kalff; Holger Cario; Susanne Holzhauer
Journal:  Front Pediatr       Date:  2022-08-01       Impact factor: 3.569

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.